Literature DB >> 19900586

Dynamic NAD(P)H post-synaptic autofluorescence signals for the assessment of mitochondrial function in a neurodegenerative disease: monitoring the primary motor cortex of G93A mice, an amyotrophic lateral sclerosis model.

Stefano Loizzo1, Massimo Pieri, Alberto Ferri, Maria Teresa Carrì, Cristina Zona, Andrea Fortuna, Stefano Vella.   

Abstract

Abnormal mitochondrial function was reported in patients and models for amyotrophic lateral sclerosis (ALS). It is therefore important to set up sensitive tools for the monitoring of active agents that enhance energy metabolism delay onset, and extend lifespan of transgenic G93A-SOD1 ALS mice. In this report, primary motor cortex slices from G93A mice at different stages of disease were studied, using NAD(P)H autofluorescence post-synaptic signals following ultraviolet stimuli, as a probe to evaluate mitochondrial function. We observed consistent age-related alterations of responses in G93A primary motor cortex slices versus controls. We conclude that NAD(P)H autofluorescence post-synaptic signal is a highly sensitive real-time technique to detect mitochondrial function failure in primary cortex from living tissues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19900586     DOI: 10.1016/j.mito.2009.11.001

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  7 in total

1.  UCP2 overexpression worsens mitochondrial dysfunction and accelerates disease progression in a mouse model of amyotrophic lateral sclerosis.

Authors:  Pablo M Peixoto; Hyun-Jeong Kim; Brittany Sider; Anatoly Starkov; Tamas L Horvath; Giovanni Manfredi
Journal:  Mol Cell Neurosci       Date:  2013-10-17       Impact factor: 4.314

2.  Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis.

Authors:  G Grasselli; S Rossi; A Musella; A Gentile; S Loizzo; L Muzio; C Di Sanza; F Errico; G Musumeci; N Haji; D Fresegna; H Sepman; V De Chiara; R Furlan; G Martino; A Usiello; G Mandolesi; D Centonze
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

Review 3.  SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments.

Authors:  Peter I Joyce; Pietro Fratta; Elizabeth M C Fisher; Abraham Acevedo-Arozena
Journal:  Mamm Genome       Date:  2011-06-26       Impact factor: 2.957

4.  Seeking homeostasis: temporal trends in respiration, oxidation, and calcium in SOD1 G93A Amyotrophic Lateral Sclerosis mice.

Authors:  Cameron W Irvin; Renaid B Kim; Cassie S Mitchell
Journal:  Front Cell Neurosci       Date:  2015-07-01       Impact factor: 5.505

5.  Dysregulated expression of death, stress and mitochondrion related genes in the sciatic nerve of presymptomatic SOD1(G93A) mouse model of Amyotrophic Lateral Sclerosis.

Authors:  Chrystian J Alves; Jessica R Maximino; Gerson Chadi
Journal:  Front Cell Neurosci       Date:  2015-09-01       Impact factor: 5.505

Review 6.  Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection.

Authors:  Sun Joo Cha; Kiyoung Kim
Journal:  Antioxidants (Basel)       Date:  2022-01-20

Review 7.  ALS Patient Stem Cells for Unveiling Disease Signatures of Motoneuron Susceptibility: Perspectives on the Deadly Mitochondria, ER Stress and Calcium Triad.

Authors:  Anjoscha Kaus; Dhruv Sareen
Journal:  Front Cell Neurosci       Date:  2015-11-19       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.